Press Releases



All Releases
View Summary Sangamo BioSciences Presents Hemophilia A Program Data At The 2016 American Society Of Hematology Meeting
Dec 5, 2016
PDF 37.8 KB Add to Briefcase
View Summary Sangamo BioSciences Makes Key Leadership Appointments To Strengthen Clinical And Commercial Capabilities
Dec 1, 2016
PDF 38.4 KB Add to Briefcase
View Summary Sangamo's Genome Editing Program for Hemoglobinopathies to Transfer to Biogen's Spin-Off Bioverativ
Nov 30, 2016
PDF 36.2 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Participation At Upcoming Investor Conferences
Nov 10, 2016
PDF 36.8 KB Add to Briefcase
View Summary Sangamo BioSciences Reports Third Quarter 2016 Financial Results
Oct 26, 2016
PDF 51.1 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Third Quarter 2016 Conference Call and Webcast
Oct 19, 2016
PDF 35.0 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Participation In Upcoming Scientific Conferences
Oct 17, 2016
PDF 37.5 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Participation At Upcoming Investor Conferences
Sep 29, 2016
PDF 38.1 KB Add to Briefcase
View Summary Sangamo BioSciences Receives Orphan Drug Designation From The FDA For SB-FIX, The First Application Of Therapeutic In Vivo Genome Editing
Sep 6, 2016
PDF 39.4 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Participation At Upcoming Investor Conferences
Aug 31, 2016
PDF 36.9 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 2016 Wedbush PacGrow Healthcare Conference
Aug 9, 2016
PDF 34.7 KB Add to Briefcase
View Summary Sangamo BioSciences Reports Second Quarter 2016 Financial Results
Aug 3, 2016
PDF 51.9 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Second Quarter 2016 Conference Call and Webcast
Jul 27, 2016
PDF 35.1 KB Add to Briefcase
View Summary Sangamo BioSciences Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A
Jul 26, 2016
PDF 41.2 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Participation At Upcoming Scientific Conferences in July
Jul 12, 2016
PDF 38.1 KB Add to Briefcase
View Summary Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II
Jun 20, 2016
PDF 42.3 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation at the Jefferies 2016 Healthcare Conference
Jun 1, 2016
PDF 34.8 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Retirement Of Edward Lanphier As President And CEO; Sandy Macrae Named As Successor
Jun 1, 2016
PDF 43.6 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Participation At Upcoming Investor Conferences
May 10, 2016
PDF 36.4 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Recent Developments From Research And ZFP Therapeutic® Programs In Multiple Presentations At Annual Meeting of the American Society of Gene and Cell Therapy
May 9, 2016
PDF 45.0 KB Add to Briefcase
Showing 1-20 of 569 Page: 1 2 3 4 5 ... 29  Next 20
Add to Briefcase = add release to Briefcase

Stock Quote

Ticker:
SGMO
Exchange:
NASDAQ
Price:
3.20
Change:
+ 0.50
Day High:
3.35
Day Low:
2.70
Volume:
1,601,307
4:00 PM ET on Dec 9, 2016

Shareholder Tools